Janney Montgomery Scott’s IceCure Medical ICCM Stock Holding History

Janney Montgomery Scott’s Portfolio ICCM Stock Details ICCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-339	Closed	-$3K	–	3140
2026 Q1	$3K	Hold	339	–	–	﹤0.01%	2737
2025 Q4	$6K	Hold	339	–	–	﹤0.01%	2908
2025 Q3	$10K	Hold	339	–	–	﹤0.01%	2847
2025 Q2	$10K	Buy	+339	New	+$10.9K	﹤0.01%	2694

Other funds holding ICCM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

SRL

Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GCM

Gunderson Capital Management Mt. Pleasant, South Carolina $370M AUM 211.56% 1-Year Est. Return

KFG

Kingdom Financial Group Peoria, Arizona $391M AUM 21.78% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Janney Montgomery Scott's ICCM Position: Q2 2026 in Review

Janney Montgomery Scott sold out of IceCure Medical (ICCM) in Q2 2026, closing a stake of 339 shares — an estimated $3K sold.

Janney Montgomery Scott first reported a position in ICCM in Q2 2025 and held it in 4 quarters. The position peaked at $10K in Q3 2025. 11 funds tracked by Wall St. Rank hold ICCM as of Q2 2026.

Janney Montgomery Scott reported no remaining IceCure Medical position as of Q2 2026 after selling out during the quarter.
Janney Montgomery Scott sold 339 IceCure Medical shares in Q2 2026, an estimated $3K.
Janney Montgomery Scott first reported a position in IceCure Medical in Q2 2025 and held it in 4 quarters.
Janney Montgomery Scott's IceCure Medical position peaked at $10K in Q3 2025.
11 funds tracked by Wall St. Rank held IceCure Medical as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.